Benefits
Real-life study in 167 women across menstrual cycles
Nexira ran a real-life observational study in 167 women across menstrual cycles, reporting benefits on three pillars: menstrual discomfort, mood and energy, and quality of life. This is real-world observational data rather than a randomized placebo-controlled trial — the methodology limits causal inference but supports tolerability and user-reported benefit at the marketed dose.
Coverage before and during menstruation
Positioned as a single ingredient supporting both PMS phase (luteal, before menstruation) and dysmenorrhea phase (during menstruation), addressing emotional symptoms in the lead-up and physical cramping during. Most PMS-targeted ingredients address one phase or the other.
Magnesium for PMS — independent evidence
Independent of BloomEase™, magnesium at 250 mg/day has shown benefit for PMS symptoms in placebo-controlled trials (Walker 1998; Quaranta 2007 Sincromag modified-release 250 mg study reported 35% reduction in total PMS scores). Marine magnesium is one of several available forms; head-to-head comparison data on absorption vs other forms is limited.
Yarrow for menstrual discomfort — traditional use
Achillea millefolium has a long traditional-use history for menstrual discomfort across European herbal medicine. Active compounds include chamazulene, flavonoids (apigenin, luteolin), and sesquiterpene lactones with documented smooth-muscle antispasmodic activity in preclinical models. Modern human clinical evidence on yarrow specifically remains limited.
Mechanism of action
Magnesium muscle relaxation and neuromuscular signaling
Magnesium is a cofactor in over 300 enzymatic reactions and is a natural calcium antagonist at smooth muscle. Adequate magnesium status supports relaxation of uterine smooth muscle, which may contribute to reduced cramp severity.
Magnesium and mood regulation
Magnesium plays a role in serotonergic signaling, NMDA receptor modulation, and HPA axis regulation. Low magnesium status is associated with mood symptoms; supplementation may modulate the mood-related dimension of PMS, though effect sizes in clinical trials are modest.
Yarrow antispasmodic compounds
Apigenin, luteolin, and sesquiterpene lactones in yarrow have demonstrated smooth-muscle antispasmodic activity in preclinical models — the proposed basis for traditional menstrual cramp use.
Clinical trials
Real-life observational study in 167 women across menstrual cycles, reporting benefits on three pillars: menstrual discomfort, mood and energy, and quality of life. This is observational data without placebo control, limiting causal inference. Specific design, primary endpoint, and statistical analysis are not yet published in peer-reviewed literature as of this writing.
Walker 1998 placebo-controlled trial reported magnesium 200 mg/day modestly reduced PMS symptoms. Quaranta 2007 Sincromag (modified-release magnesium 250 mg) open-label trial reported ~35% reduction in total PMS scores. Evidence is mixed across the broader literature; single-nutrient effects are typically modest. These are independent magnesium studies, not BloomEase™ specifically.